This oncology biotech advancing targeted therapies reported a notable insider sale amid ongoing clinical-stage development.

Here is how Adicet Bio, Inc. (ACET) and Biodesix, Inc. (BDSX) have performed compared to their sector so far this year.

Investors might want to bet on Korro Bio, Inc. (KRRO), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...

The biotech sector, once hailed as the next growth engine for the stock market, is experiencing a sharp decline. While the immediate trigger is the "AI frenzy," analysts point to long-standing ...

On June 25, 2026, investors tracked deal progress as Bio-Techne shares responded to the proposed buyout terms.

Cabaletta offers a de-risked, breadth-first CAR-T platform for autoimmune diseases, with strong EULAR 2026 data and a ...

Bio-Rad provides essential instruments and reagents used in labs worldwide, while Charles River offers critical research models and services for drug discovery. Investors often compare these two ...

That is a big risk investors take when trying to find the winners and losers within the biotech sector. While we made the ...

Bio-Techne rallied for a third straight day on Thursday, surging 20.08 percent to close at $70.70 apiece, as investors ...

Germany’s Merck KGaA will buy Bio-Techne Corp. in a deal worth $11.3 billion, one of the largest acquisitions in Minnesota ...

BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management and biometric authentication technologies, today announced that The Nasdaq Stock Market LLC has notified ...

CNBC's Becky Quick sat down with BIO CEO John Crowley in the Season 1 finale of the CNBC Cures podcast. Watch the full ...